Ligand profile
ZINC2069590151
Virtual-screening candidate from ZINC.
Bound to: VK055_1764 — galactose-1-phosphate uridylyltransferase
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC2069590151- UniProt (similar protein)
P07902-2- Tanimoto
- 0.711
- Target protein
- VK055_1764
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 108.3
- −1 ≤ LogP ≤ 5 -1.98
- MW ≤ 500 Da 260.2
- LogP ≤ 5 -1.98
- H-bond donors ≤ 5 3
- H-bond acceptors ≤ 10 6
- Rotatable bonds ≤ 10 3
- TPSA ≤ 140 Ų 108.3
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
COC[C@@H]1O[C@H](N2CCC(=O)NC2=O)[C@@H](O)[C@H]1OCOC[C@@H]1O[C@H](N2CCC(=O)NC2=O)[C@@H](O)[C@H]1O
InChI=1S/C10H16N2O6/c1-17-4-5-7(14)8(15)9(18-5)12-3-2-6(13)11-10(12)16/h5,7-9,14-15H,2-4H2,1H3,(H,11,13,16)/t5-,7-,8-,9-/m0/s1InChI=1S/C10H16N2O6/c1-17-4-5-7(14)8(15)9(18-5)12-3-2-6(13)11-10(12)16/h5,7-9,14-15H,2-4H2,1H3,(H,11,13,16)/t5-,7-,8-,9-/m0/s1
HENIRZGCVXKJIP-ZITKLIBNSA-NHENIRZGCVXKJIP-ZITKLIBNSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- H2U
- Homolog
- P07902-2
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC2069590151 →
- ZINC ZINC20 ZINC2069590151 →
- UniProt UniProt P07902-2 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC2069590151”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_1764.
PDB 4
Ligands co-crystallized with this protein (structural evidence).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).